UNSPSC 51162740: Tasuldine

This classification denotes a mucolytic agent with the molecular formula C10H9N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) S4ZCE64Q3O, chemically known as pyrimidine, 2-((3-pyridinylmethyl)thio)- but more generally known as tasuldine, which bears US NIH Compound Identifier 65666. European Medicines Agency schedules Tasuldine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10835MIG. The term TASULDINE is an International Non-Proprietary Name.

UNSPSC 51162740 Tasuldine (Commodity) covers pharmaceutical products and related health-care supplies that state and local governments procure through competitive bidding and cooperative purchasing vehicles. Recent solicitations show state and local procurement of naloxone and drug deactivation systems for community health initiatives, as well as generic multi-source pharmaceuticals and over-the-counter products distributed across public facilities. The issuing bodies include county health departments (Seminole County, Florida) and multistate cooperative purchasing alliances administered by state procurement offices (Minnesota Department of Administration). These jurisdictions use both individual competitive bids and cooperative agreements to source pharmaceutical inventory on fixed-fee or tiered-pricing bases, with quarterly or ongoing delivery schedules. Vendors must comply with federal drug-supply requirements including cGMP certification, DSCSA compliance, and FDA approval, along with standard state and local contracting obligations such as drug-free workplace certification, E-Verify employment verification, and specified insurance coverage.

Activity appears concentrated in Florida and the Upper Midwest, with recent opportunities spanning individual county procurements and multistate cooperative arrangements. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a bid deadline of July 26, 2023. The Minnesota Department of Administration's Office of State Procurement, acting through MMCAP (Minnesota Multistate Cooperative Purchasing Alliance), posted RFP S1070000015802 on January 20, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products across participating state and local facilities including Oregon, with proposals due March 26, 2026 and awards effective July 1, 2026. Both solicitations require vendor pricing in standardized formats and impose performance penalties or three-month probationary termination rights, with contract terms typically ranging from two to three years.